Evidence map›Paper›PMID 27381289›Full record

ArticlemBio2016

Ehrlichia chaffeensis TRP120 Activates Canonical Notch Signaling To Downregulate TLR2/4 Expression and Promote Intracellular Survival.

Taslima T Lina, Paige S Dunphy, Tian Luo, Jere W McBride

Open access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 57 citations in OpenAlex.

  1. Asiatic Acid AttenuatesInternational journal of molecular sciences · 2026
    Article
  2. Article
  3. Cell signaling inFrontiers in cellular and infection microbiology · 2025
    Review
  4. Article
  5. mBio · 2024
    Article
  6. Review
  7. Article
  8. Infection and immunity · 2023
    Article
  9. Infection and immunity · 2023
    Article
  10. bioRxiv : the preprint server for biology · 2023
    Article
  11. Type 1 secretion system and effectors in Rickettsiales.Frontiers in cellular and infection microbiology · 2023
    Review
  12. Frontiers in cellular and infection microbiology · 2023
    Review
  13. Article
  14. mBio · 2022
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. RevisitingMicroorganisms · 2021
    Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Taslima T LinaDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Paige S DunphyDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Tian LuoDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA.
Jere W McBrideDepartment of Pathology, University of Texas Medical Branch, Galveston, Texas, USA Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, USA Sealy Center for Vaccine Development, University of Texas Medical Branch, Galveston, Texas, USA Institute for Human Infections and Immunity, University of Texas Medical Branch, Galveston, Texas, USA jemcbrid@utmb.edu.
The University of Texas Medical Branch at Galveston · US

Funding

Ehrlichia T1S Effector Regulation of Host Gene TranscriptionR01AI106859 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2014 to 2017
$1.5M
Ehrlichia Type-1 Secreted Effectors Exploit Host SUMO PathwaysR21AI105536 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2013 to 2014
$421k
Notch signaling and functional relevance during Ehrlichia chaffeensis infectionR21AI123610 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2017 to 2018
$420k
Wnt signaling during Ehrlichia infectionR21AI126144 · NIAID · UNIVERSITY OF TEXAS MED BR GALVESTON · PI MCBRIDE, JERE W · 2016 to 2017
$420k
NIAID NIH HHS R01 AI106859NIAID NIH HHS R21 AI105536NIAID NIH HHS R21 AI123610NIAID NIH HHS R21 AI126144
6 · The paper itself

Abstract

unlabelledEhrlichia chaffeensis preferentially targets mononuclear phagocytes and survives through a strategy of subverting innate immune defenses, but the mechanisms are unknown. We have shown E. chaffeensis type 1 secreted tandem repeat protein (TRP) effectors are involved in diverse molecular pathogen-host interactions, such as the TRP120 interaction with the Notch receptor-cleaving metalloprotease ADAM17. In the present study, we demonstrate E. chaffeensis, via the TRP120 effector, activates the canonical Notch signaling pathway to promote intracellular survival. We found that nuclear translocation of the transcriptionally active Notch intracellular domain (NICD) occurs in response to E. chaffeensis or recombinant TRP120, resulting in upregulation of Notch signaling pathway components and target genes notch1, adam17, hes, and hey Significant differences in canonical Notch signaling gene expression levels (>40%) were observed during early and late stages of infection, indicating activation of the Notch pathway. We linked Notch pathway activation specifically to the TRP120 effector, which directly interacts with the Notch metalloprotease ADAM17. Using pharmacological inhibitors and small interfering RNAs (siRNAs) against γ-secretase enzyme, Notch transcription factor complex, Notch1, and ADAM17, we demonstrated that Notch signaling is required for ehrlichial survival. We studied the downstream effects and found that E. chaffeensis TRP120-mediated activation of the Notch pathway causes inhibition of the extracellular signal-regulated kinase 1/2 (ERK1/2) and p38 mitogen-activated protein kinase (MAPK) pathways required for PU.1 and subsequent Toll-like receptor 2/4 (TLR2/4) expression. This investigation reveals a novel mechanism whereby E. chaffeensis exploits the Notch pathway to evade the host innate immune response for intracellular survival. IMPORTANCE: E. chaffeensis is an obligately intracellular bacterium and the etiologic agent of human monocytotropic ehrlichiosis (HME), an emerging life-threatening tick-borne zoonosis. Mechanisms by which E. chaffeensis establishes intracellular infection and avoids innate host defenses are not understood, but functionally relevant host-pathogen interactions with type 1 secreted TRP effectors are essential for the ehrlichial cellular reprogramming strategy. This study provides further insight into the molecular strategies used by obligately intracellular pathogens such as E. chaffeensis, which have small genomes and a limited number of effector proteins and exploit evolutionarily conserved host cell programs such as Notch signaling to promote infection and intracellular survival.

Indexed as

Down-RegulationSignal TransductionBacterial ProteinsCell LineEhrlichia chaffeensisHost-Pathogen InteractionsHumansImmune EvasionMicrobial ViabilityMonocytesReceptor, Notch1Toll-Like Receptor 2Toll-Like Receptor 4Bacterial ProteinsNOTCH1 protein, humanReceptor, Notch1TLR2 protein, humanTLR4 protein, humanToll-Like Receptor 2Toll-Like Receptor 4

Identifiers

PMID27381289
PMCPMC4958247
OpenAlexW2474534397

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.